All Stories

  1. 2-{N-[(2,4,5-trichlorophenoxy) acetyl]-N-methylamino}-3-pyrrolidinepropanamide analogs as potential antagonists of Urotensin II receptor

    Article • Journal of Receptors and Signal Transduction, January 2023, Taylor & Francis

    Dr. MAHESH KUMAR SETH

  2. Toxicity Study of 3-Thienylalanine- Ornithine-Proline (TOP) Using as Novel ACE Inhibitor

    Article • International Journal of Peptide Research and Therapeutics, September 2022, Springer Science + Business Media

    Dr. MAHESH KUMAR SETH

  3. “Association of Leptin with Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis”

    Article • The Journal of Obstetrics and Gynecology of India, August 2021, Springer Science + Business Media

    Dr. MAHESH KUMAR SETH

  4. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice

    Article • European Journal of Pharmacology, November 2020, Elsevier

    Dr. MAHESH KUMAR SETH

  5. Effects of a novel ACE inhibitor, 3-(3-thienyl)-L-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in L-NAME-induced hypertensive rats

    Article • Drug Design Development and Therapy, April 2016, Dove Medical Press

    Dr. MAHESH KUMAR SETH

  6. Sulfur-Containing Angiotensin-Converting Enzyme Inhibitor 3-Thienylalanine-Ornithyl-Proline Activates Endothelial Function and Expression of Genes Involved in Renin–Angiotensin System

    Article • Journal of Cardiovascular Pharmacology, April 2013, Wolters Kluwer Health

    Dr Parbati Biswas, Dr. MAHESH KUMAR SETH

  7. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa

    Article • European Journal of Pharmacology, January 2011, Elsevier

    Dr. MAHESH KUMAR SETH

  8. Pharmacology of a Novel, Orally Active PDE4 Inhibitor

    Article • Pharmacology, January 2009, Karger Publishers

    Dr Pawan Sharma, Dr. MAHESH KUMAR SETH